MRSN
NASDAQ
$29.08
Mersana Therapeutics Inc (MRSN)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$145M
Revenue 5Y CAGR
+109.71%
Free Cash Flow Yield
-51.16%
Price Chart
Valuation
Market Cap$145M
Profitability
Total Revenue (TTM)$33M
Gross Profit (TTM)-$36M
EBITDA-$66M
Profit Margin-68.5%
EPS-$14.27
Financial Health
Free Cash Flow Yield-51.16%
Growth & Risk
EPS 5Y CAGR-15.54%
Revenue 5Y CAGR+109.71%
FCF 5Y CAGR+1.15%
Sharpe Ratio0.58